We are a microglia-focused company dedicated to improving the lives of patients, caregivers and families affected by rare and common neurodegenerative diseases by pursuing the development of disease-modifying therapeutics to restore the vigilance of microglia. Microglia are the sentinel immune cells of the brain and play a critical role in maintaining central nervous system (CNS) […]

We intend to focus our search on wireless telecommunications companies. Our sponsor is an affiliate of Mach FM, a wireless telecommunications business, led by a management team with a shared vision and passion for delivering disruptive technologies to the end-consumer. Jaymes Winters, our CEO, has over 15 years of experience as a CEO in the […]

We intend to focus on businesses in the education, training and education technology (“EdTech”) industries, specifically in Asia (excluding China). Our amended and restated certificate of incorporation will provide that we shall not undertake our initial business combination with any entity with its principal business operations in China (including Hong Kong and Macau). Our management […]

(Note: Justworks, Inc. withdrew its IPO in an SEC letter dated July 13, 2022. The company had filed to go public (S-1) on Dec. 16, 2021. Justworks postponed its IPO on Jan. 12, 2022, “due to market conditions” – hours ahead of when the IPO was scheduled to price for a debut on Jan. 13. […]

We intend to focus on businesses in the technology metals (“Technology Metals”) and energy transition critical materials (“ETMs”) sectors and the geographic region of the company’s search for a prospective target will not include the People’s Republic of China (“China” or the “PRC”) or the special administrative regions of Hong Kong or Macau, and we […]

Although we intend to target North American or European companies, our focus will be to acquire a business in the healthcare industry in the United States. We believe the healthcare industry, particularly the life sciences sector, represents an enormous and growing target market with a large number of potential target acquisition opportunities. More specifically, we […]

We are a newly organized blank check company incorporated in March 2021. We seek to capitalize on the significant experience and contacts of our management team, led by Daniel J. O’Connor, in consummating an initial business combination. Although we may pursue an initial business combination opportunity in any business, industry, sector or geographical location, we intend to focus on […]

We intend to focus on targets in the TMT (telecom, media and technology) sector.  (**Note: About 10 qualified institutional buyers had each indicated an interest in buying up to 9.99 percent of the units in the IPO – or in aggregate up to 99.9 percent of the deal, the prospectus says.) (Note: Sagaliam Acquisition Corp. priced […]

We will search for target businesses involved in EV (electric vehicles) technology, smart mobility or sustainable transportation and related businesses in the Asia Pacific region, primarily Southeast Asia, where our management team has extensive experience in information technology, transportation operations and manufacturing industries. (Note: Arogo Capital Acquisition Corp. announced the pricing of its downsized SPAC […]

It is our intention to pursue prospective targets that are focused on healthcare innovation. We anticipate targeting what are traditionally known as “small cap” companies domiciled in North America, Europe and/or the Asia Pacific (“APAC”) regions that are developing assets in the biopharmaceutical, medical technology/medical device and diagnostics space which aligns with our management team’s […]